Patients with myeloproliferative neoplasms and COVID-19 have increased rates of arterial thrombosis.

Orly LeivaUmberto CampiaJulia SnyderBriana M BarnsSamantha RizzoCandrika D KhairaniAndrew BrunnerDavid J KuterRebecca Karp LeafRachel P RosovskyKatayoon GoodarziLarissa BornikovaAmir FathiSamuel Z GoldhaberGabriela HobbsGregory Piazza

Published in: Research and practice in thrombosis and haemostasis (2022)

Among patients with COVID-19, MPN patients had higher risk of arterial thrombosis but not VTE, bleeding, and death compared with non-MPN patients. Larger studies are needed to confirm our findings given the limited sample size.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
coronavirus disease
venous thromboembolism
atrial fibrillation
patient reported outcomes